Evidence of Presentation of Multiple HIV-1 Cytotoxic T Lymphocyte Epitopes by HLA-B*3501 Molecules That Are Associated with the Accelerated Progression of AIDS

Journal of Immunology

Volumn 158, Issue 10, 1997, Pages 5026-5034

  Tomiyama, Hiroko ^a   Miwa, Kiyoshi ^b   Shiga, Hajime ^a   Moore, Yuki Ikeda ^a   Oka, Shinichi ^a   Iwamoto, Aikichi ^a   Kaneko, Yutaro ^b   Takiguchi, Masafumi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b AJINOMOTO CO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B35 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; PEPTIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CHEMISTRY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPITOPE MAPPING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ANTIGEN-PRESENTING CELLS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPE MAPPING; HIV ANTIGENS; HIV-1; HLA-B35 ANTIGEN; HUMANS; IMMUNITY, CELLULAR; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0031570033     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initiai control of viremia in primary human immunodeficiency virus type I syndrome. J. Virol. 68:4650.
2. + T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370:463.
3. Langlade-Demoyen, P., N. Ngo-Giang-Huong, F. Ferchal, and E. Oksenhendler. 1994. Human immunodeficiency virus (HIV) nef-specific cytotoxic T lymphocytes in noninfected heterosexual contact of HIV-infected patients. J. Clin. Invest. 93:1293.
4. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, M. Takiguchi, T. Schultz, A. McMichael, and H. Whittle. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nat. Med. 1:59.
5. Klein, M. R., C. A. van Baalen, A. M. Holwerda, S. R. K. Garde, R. J. Bende, I. P. M. Keet, J. K. M. Eeftinck-Schattenkerk, A. D. M. E. Osterhaus, H. Schuitemaker, and F. Miedema. 1995. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med. 181:1365.
6. Nowak, M. A., R. M. Anderson, A. R. McLean, T. F. W. Wolfs, J. Goudsmit, and R. M. May. 1991. Antigenic diversity thresholds and the development of AIDS. Science 254:963.
7. Wolinsky, S. M., B. T. M. Korber, A. U. Neumann, M. Daniels, K. J. Kunstman, A. J. Whetsell, M. R. Furtado, Y. Cao, D. D. Ho, J. T. Safrit, R. A. Koup. 1996. Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science 272:537.
8. Klenerman, P., S. Rowland-Jones, S. McAdam, J. Edwards, S. Daenke, D. Lalloo, B. Köppe, W. Rosenberg, D. Boyd, A. Edwards, P. Giangrande, R. E. Phillips, and A. J. McMichael. 1994. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369:403.
9. Meier, U. C., P. Klenerman, P. Griffin, W. James, B. Koppe, B. Larder, A. McMichael, and R. Phillips. 1995. Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants. Science 270:1360.
10. Smeraldi, R. S., G. Fabio, A. Lazzarin, N. Eisera, M. Moroni, and C. Zanussi. 1986. HLA-associated susceptibility to acquired immunodeficiency syndrome in Italian patients with human-immunodeficiency-virus infection. Lancet 2:1187.
11. Smeraldi, R. S., G. Fabio, A. Lazzarin, N. Eisera, C. U. Foppa, M. Moroni, and C. Zanussi. 1988. HLA-associated susceptibility to AIDS: HLA B35 is a major risk factor for Italian HIV-infected intravenous drug addicts. Hum. Immunol. 22:73.
12. Plum, G., E. Siebel, C. Bendick, H. Rasokat, M. Braun, H. Krickeberg, G. Mauff, and the ARC-IVIG Study Group Colone/Berne. 1990. Major histocompatibility complex class I to III allotypes in patients with AIDS-related complex/Walterreed 5, disseminated Kaposi's sarcoma and in normal controls. Vox Sang. 59:15.
13. Itscu, S., U. Mathur-Wagh, M. L. Skovron, L. J. Brancato, M. Marmor, A. Zeleniuch-Jacquotte, and R. Winchester. 1992. HLA-B35 is associated with accelerated progression to AIDS. J. AIDS 5:37.
14. Sahmoud, T., Y. Laurian, C. Gazengel, Y. Sultan, C. Gautreau, and D. Costagliola. 1993. Progression to AIDS in French haemophiliacs: association with HLA-B35. AIDS 7:497.
15. Itescu, S., S. Rose, E. Dwyer, and R. Winchester. 1995. Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection. Hum. Immunol. 42:31.
16. Kaslow, R. A., M. Carrington, R. Apple, L. Park, A. Muñoz, A. J. Saah, J. J. Goedert, C. Winkler, S. J. O'Brien, C. Rinaldo, R. Detels, W. Blattner, J. Phair, H. Erlich, and D. L. Mann. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405.
17. Shiga, H., T. Shioda, H. Tomiyama, Y. Takamiya, S. Oka, S. Kimura, Y. Yamaguchi, T. Gojoubori, H. G. Rammensee, K. Miwa, and M. Takiguchi. 1996. Identification of multiple HIV-1 cytotoxic T-cell epitopes presented by human leukocyte antigen B35 molecules. AIDS 10:1075.
18. Sekimata, M., H. Hayashi, S. Nakayama, K. Kano, and M. Takiguchi. 1989. Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51. Immunogenetics 30:229.
19. Takamiya, Y., C. Schönbach, K. Nokihara, M. Yamaguchi, S. Femme, K. Kano, K. Egawa, and M. Takiguchi. 1994. HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules. Int. Immunol. 6:255.
20. Takiguchi, M., G. Kawaguchi, M. Sekimata, M. Hiraiwa, A. Kariyone, and Y. Takamiya. 1994. The role of the conserved residue in pocket A and polymorphic residue in pocket E of HLA-B*3501 in presentation of human minor histocompatibility peptides to T cells. Int. Immunol. 6:1345.
21. Yamamoto, J., A. Kariyone, N. Akiyama, K. Kano, and M. Takiguchi. 1990. Presentation of human minor histocompatibility antigens by HLA-B35 or HLA-B38 molecules. Proc. Natl. Acad. Sci. USA 87:2583.
22. Schönbach, C., M. Ibe, H. Shiga, Y. Takamiya, K. Miwa, K. Nokihara, and M. Takiguchi. 1995. Fine tuning of peptide binding to HLA-B*3501 molecules by nonanchor residues. J. Immunol. 154:5951.
23. Zemmour, J., A. M. Little, D. J. Schendel, and P. Parham. 1992. The HLA-A, B "negative" mutant cell line ClR expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 148:1941.
24. + T cells in the central region of the HIV-1 Nef protein. J. Immunol. 146:1560.
25. Walker, B. D., C. Flexner, K. Birch-Limberger, L. Fisher, T. J. Paradis, A. Aldovini, R. Young, B. Moss, and R. T. Schooley. 1989. Long-term culture and fine specificity of human cytotoxic T-lymphocyte clones reactive with human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:9514.
26. Nixon, F. D., and A. J. McMichael. 1991. Cytotoxic T-cell recognition of HlV proteins and peptides. AIDS 5:1049.
27. Dadaglio, G., A. Leroux, P. Langlade-Demoyen, E. M. Bahraoui, F. Traincard, R. Fisher, and F. Plata. 1993. Epitope recognition of conserves HIV envelope sequences by human cytotoxic T lymphocytes. J. lmmunol. 147:2302.
28. + T cells binds very tightly to the restricting class I major histocompatibility complex protein on intact cells but not to the purified class I protein. Proc. Natl. Acad. Sci. USA 88:11276.
29. Johnson, R. P., A. Trocha, L. Yang, G. P. Mazzara, D. L. Panicali, T. M. Buchanan, and B. D. Walker. 1991. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes. J. Immunol. 147:1512.
30. Tsomides, T. J., A. Aldovini, R. P. Johnson, B. D. Walker, R. A. Young, and H. N. Eisen. 1994. Naturally processed viral peptides recognized by cytotoxic T lymphocytes on cells chronically infected by human immunodeficiency virus type 1. J. Exp. Med. 180:1283.
31. Gagliardi, M. C., G. D. Petrillo, S. Salemi, L. Boffa, M. G. Lngobardi, P. Dellabona, G. Casorati, N. Tanigaki, R. Harris, A. Lanzavecchia, and V. Barnaba. 1995. Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol. 7:1741.
32. Dupuis, M., S. K. Kundu, and T. C. Merigan. 1995. Characterization of HLA-A*0201-restricted cytotoxic T cell epitopes in conserved regions of the HfV type 1 gp160 protein. J. lmmunol. 155:2232.
33. van der Burg, S. H., M. R. Klein, C. H. J. van de Velde, W. M. Kast, F. Miedema, and C. J. M. Melief. 1995. Induction of a primary human cytotoxic T-lymphocyte response against a novel conserved epitope in a functional sequence of HIV-1 reverse transcriptase. AIDS 9:121.
34. Brander, C., W. J. Pichler, and G. Corradin. 1995. Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccine. Clin. Exp. Immunol. 101:107.
35. Hadida, F., G. Haas, N. Zimmermann, A. Hosmalin, R. Spohn, A. Samri, G. Jong, P. Debre, and B. Autran. 1995. CTLs from lymphoid organs recognize an optimal HLA-A2-restricted and HLA-B52-restricted nonapeptide and several epitopes in the C-terminal region of HIV-1 nef. J. Immunol. 154:4174.
36. Harrer, E., T. Harrer, P. Barbosa, M. Feinberg, R. P. Johnson, S. Buchbinder, and B. D. Walker. 1996. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2-restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J. Infect. Dis. 173:476.
37. + CTL. J. Immunol. 154:6140.
38. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C. R. M. Bangham, and A. J. McMichael. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375:606.
39. McAdam, S., P. Klenerman, L. Tussey, S. Rowland-Jones, D. Lalloo, R. Phillips, A. Edwards, P. Giangrande, A. L. Brown, F. Gotch, and A. McMichael. 1995. Immunogenic HIV variant peptides that bind to HLA-B8 can fail to stimulate cytotoxic T lymphocyte responses. J. Immunol. 155:2729.
40. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J. Choppin, J.-P. Levy, J.-G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immuogenic region of the human immunodefieiency virus 1 NEF protein. J. Exp. Med. 180:1129.